Unknown NA INTERVENTIONAL 2-arm NCT02836977

Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital

Updated 8 times since 2017 Last updated: Feb 6, 2017 Started: Mar 31, 2016 Primary completion: Mar 31, 2017 Completion: Feb 29, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Stage III Colon Cancer and is currently ongoing. Kaohsiung Medical University Chung-Ho Memorial Hospital leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Apr 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Apr 2024 [monthly]

Active Not Recruiting NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Active Not Recruiting NA
Feb 2017 — Jun 2018 [monthly]

Active Not Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting NA

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kaohsiung Medical University Chung-Ho Memorial Hospital

Data source: Kaohsiung Medical University Chung-Ho Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kaohsiung City, Taiwan